Neurodegenerative Diseases

Title Publication Date Language Citations
Red Blood Cells Are the Major Source of Alpha-Synuclein in Blood2008/01/01English334
Cognitive Impairment in Parkinson’s Disease: The Dual Syndrome Hypothesis2012/10/03English331
Amyloid-β Aggregation2007/01/01English235
Neuroinflammation – An Early Event in Both the History and Pathogenesis of Alzheimer’s Disease2010/01/01English182
Hypermetabolism in ALS: Correlations with Clinical and Paraclinical Parameters2005/01/01English177
Alzheimer’s Disease in the Retina: Imaging Retinal Aβ Plaques for Early Diagnosis and Therapy Assessment2012/01/01English138
Activation of the Unfolded Protein Response Is an Early Event in Alzheimer’s and Parkinson’s Disease2012/01/01English134
Celastrol Blocks Neuronal Cell Death and Extends Life in Transgenic Mouse Model of Amyotrophic Lateral Sclerosis2005/01/01English125
Neuroinflammation and Blood-Brain Barrier Changes in Capillary Amyloid Angiopathy2012/01/01English122
<i>Caenorhabditis elegans</i> MPP<sup>+</sup> Model of Parkinson’s Disease for High-Throughput Drug Screenings2004/01/01English120
Natalizumab: Targeting α<sub>4</sub>-Integrins in Multiple Sclerosis2007/12/14English117
Inhibition of Microglial Activation Protects Hippocampal Neurogenesis and Improves Cognitive Deficits in a Transgenic Mouse Model for Alzheimer’s Disease2012/01/01English116
Excitotoxicity and Amyotrophic Lateral Sclerosis2005/01/01English112
The Vascular Hypothesis of Alzheimer’s Disease: Bench to Bedside and Beyond2010/01/01English111
Mitochondria in Amyotrophic Lateral Sclerosis: A Trigger and a Target2004/01/01English106
Soluble Beta-Amyloid Leads to Mitochondrial Defects in Amyloid Precursor Protein and Tau Transgenic Mice2008/01/01English105
Axonal Degeneration in Motor Neuron Disease2007/01/01English105
Extravascular CD3+ T Cells in Brains of Alzheimer Disease Patients Correlate with Tau but Not with Amyloid Pathology: An Immunohistochemical Study2018/01/01English104
Assembly, Trafficking and Function of γ-Secretase2006/01/01English103
Role of p53 in Neurodegenerative Diseases2011/10/28English99
Significance of MRI in Diagnosis and Differential Diagnosis of Parkinson’s Disease2010/01/01English90
Peripheral Inflammatory Cytokines as Biomarkers in Alzheimer’s Disease and Mild Cognitive Impairment2007/01/01English89
Leucine-Rich Repeat Kinase 2 Gene-Associated Disease: Redefining Genotype-Phenotype Correlation2010/01/01English88
Clinical Criteria for the Diagnosis of Parkinson’s Disease2010/01/01English85
Amyloid-β-Derived Diffusible Ligands Cause Impaired Axonal Transport of Mitochondria in Neurons2010/01/01English84
Neuropathological Aspects of Alzheimer Disease, Parkinson Disease and Frontotemporal Dementia2008/01/01English83
Prevalence and Impact of Cerebrovascular Lesions in Alzheimer and Lewy Body Diseases2010/01/01English81
Lead Exposure as a Risk Factor for Amyotrophic Lateral Sclerosis2005/01/01English81
Progress in the Active Immunotherapeutic Approach to Alzheimer’s Disease: Clinical Investigations into AN1792-Associated Meningoencephalitis2008/01/01English80
Pathophysiology of Neuronal Energy Crisis in Alzheimer’s Disease2008/01/01English80